Akston Biosciences Corp
CIK:
0001776612
Company Information
Industry
Pharmaceutical Preparations
SIC Code
2834
Entity Type
other
State of Incorporation
DE
Business Address
100 CUMMINGS CENTER SUITE 454C, BEVERLY, MA, 01915
Mailing Address
100 CUMMINGS CENTER SUITE 454C, BEVERLY, MA, 01915
Phone
978-969-3381
Fiscal Year End
1231
EIN
000000000
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| S-1/A IPO registration amendment | February 18, 2026 | View on SEC |
| S-1/A IPO registration amendment | January 15, 2026 | View on SEC |
| S-1/A IPO registration amendment | December 8, 2025 | View on SEC |
| S-1/A IPO registration amendment | November 17, 2025 | View on SEC |
| S-1 IPO registration statement | October 8, 2025 | View on SEC |
IPO Filings
S-1
October 8, 2025
- Specializes in biologics for companion animals (e.g., insulin, cancer treatments) in a $152B+ pet care market
- Pet medicine market growing at 6.6% annually with focus on chronic conditions in aging pets
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.